Report overview
The global Transdermal Analgesic Patch market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The U.S. market size is estimated at $ million in 2024, while China is to reach $ million.
Methyl Salicylate-based Patch segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Transdermal Analgesic Patch include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, Teva Pharmaceutical, Beijing Tide Pharmaceutical, Chattem, Nitto Denko, Gr�nenthal, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Transdermal Analgesic Patch manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Transdermal Analgesic Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Analgesic Patch. This report contains market size and forecasts of Transdermal Analgesic Patch in global, including the following market information:
Global Transdermal Analgesic Patch market revenue, 2020-2025, 2026-2032, ($ millions)
Global Transdermal Analgesic Patch market sales, 2020-2025, 2026-2032, (K Units)
Global top five Transdermal Analgesic Patch companies in 2024 (%)
Total Market by Segment:
Global Transdermal Analgesic Patch market, by Type, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Transdermal Analgesic Patch market segment percentages, by Type, 2024 (%)
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Global Transdermal Analgesic Patch market, by Application, 2020-2025, 2026-2032 ($ Millions) & (K Units)
Global Transdermal Analgesic Patch market segment percentages, by Application, 2024 (%)
Rx Channel
OTC Channel
Global Transdermal Analgesic Patch market, by region and country, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Transdermal Analgesic Patch market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal Analgesic Patch revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Transdermal Analgesic Patch revenues share in global market, 2024 (%)
Key companies Transdermal Analgesic Patch sales in global market, 2020-2025 (estimated), (K Units)
Key companies Transdermal Analgesic Patch sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Gr�nenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy�s Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transdermal Analgesic Patch, market overview.
Chapter 2: Global Transdermal Analgesic Patch market size in revenue and volume.
Chapter 3: Detailed analysis of Transdermal Analgesic Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal Analgesic Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Transdermal Analgesic Patch capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
